By screening hundreds of sybodies (synthetic mini-antibodies), scientists have identified one that might stop SARS-CoV-2 from infecting human cells.…
By Dorota Badowska
Scientists hope that a legacy of the novel coronavirus in recovered COVID-19 patients – antibodies in their blood – could lead to drugs to treat…
By Adam Gristwood
New EMBL spinoff company Velabs Therapeutics aims to speed up discovery of therapeutic…
By Iris Kruijen
Looking for past print editions of EMBLetc.?
Browse our archive, going back 20 years.